Immune checkpoint blockade in advanced hepatocellular carcinoma: an update and critical review of ongoing clinical trials

od Harding, James J
izdano v Future Oncol (2018)

Understanding and quantifying the immune microenvironment in hepatocellular carcinoma

od Osorio, Juan C., Harding, James J.
izdano v Transl Gastroenterol Hepatol (2018)

Predicting responsiveness to sorafenib: can the determination of FGF3/FGF4 amplifications enrich for clinical benefit?

od Harding, James J., Abou-Alfa, Ghassan K.
Izdano 2014

Cutis Verticis Gyrata in Association With Vemurafenib and Whole-Brain Radiotherapy

od Harding, James J., Barker, Christopher A., Carvajal, Richard D., Wolchok, Jedd D., Chapman, Paul B., Lacouture, Mario E.
izdano v J Clin Oncol (2014)

Adjuvant medications that improve survival after locoregional therapy

od Boas, F. Edward, Ziv, Etay, Yarmohammadi, Hooman, Brown, Karen T., Erinjeri, Joseph P., Sofocleous, Constantinos T., Harding, James J., Solomon, Stephen B.
izdano v J Vasc Interv Radiol (2017)

Aspirin Is Associated With Improved Liver Function After Embolization of Hepatocellular Carcinoma

od Boas, F. Edward, Brown, Karen T., Ziv, Etay, Yarmohammadi, Hooman, Sofocleous, Constantinos T., Erinjeri, Joseph P., Harding, James J., Solomon, Stephen B.
izdano v AJR Am J Roentgenol (2019)

Pharmacokinetic Assessment of (18)F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer

od Grkovski, Milan, Goel, Reema, Krebs, Simone, Staton, Kevin D., Harding, James J., Mellinghoff, Ingo K., Humm, John L., Dunphy, Mark P.S.
izdano v J Nucl Med (2020)

Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma

od Harding, James J., Do, Richard K., Yaqubie, Amin, Cleverly, Ann, Zhao, Yumin, Gueorguieva, Ivelina, Lahn, Michael, Benhadji, Karim A., Kelley, Robin K., Abou‐Alfa, Ghassan K.
izdano v Cancer Med (2021)

Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels

od Lee, Andrew W., Wang, Nan, Hornell, Tara M.C., Harding, James J., Deshpande, Chetan, Hertel, Laura, Lacaille, Vashti, Pashine, Achal, Macaubas, Claudia, Mocarski, Edward S., Mellins, Elizabeth D.
Izdano 2011

Acute myeloid leukemia masquerading as hepatocellular carcinoma

od Abu-Zeinah, Ghaith F., Weisman, Paul, Ganesh, Karuna, Katz, Seth S., Dogan, Ahmet, Abou-Alfa, Ghassan K., Stein, Eytan M., Jarnagin, William, Mauro, Michael J., Harding, James J.
izdano v J Gastrointest Oncol (2016)

Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor

od Harding, James J., Bauer, Todd M., Tan, Daniel S. W., Bedard, Philippe L., Rodon, Jordi, Doi, Toshihiko, Schnell, Christian, Iyer, Varsha, Baffert, Fabienne, Radhakrishnan, Rajkumar, Fabre, Claire, Juric, Dejan
izdano v Invest New Drugs (2018)

Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience

od Glassman, Danielle C., Palmaira, Randze L., Covington, Christina M., Desai, Avni M., Ku, Geoffrey Y., Li, Jia, Harding, James J., Varghese, Anna M., O’Reilly, Eileen M., Yu, Kenneth H.
izdano v BMC Cancer (2018)

Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation

od Momtaz, Parisa, Harding, James J., Ariyan, Charlotte, Coit, Daniel G., Merghoub, Taha, Gasmi, Billel, You, Daoqi, Viale, Agnes, Panageas, Katherine S., Samoila, Aliaksandra, Postow, Michael A., Wolchok, Jedd D., Chapman, Paul B.
izdano v Oncotarget (2017)

Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment

od Callahan, Margaret K., Rampal, Raajit, Harding, James J., Klimek, Virginia M., Chung, Young Rock, Merghoub, Taha, Wolchok, Jedd D., Solit, David B., Rosen, Neal, Abdel-Wahab, Omar, Levine, Ross L., Chapman, Paul B.
Izdano 2012

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib

od El Dika, Imane, Capanu, Marinela, Chou, Joanne F., Harding, James J., Ly, Michele, Hrabovsky, Anna D., Do, Richard K.G., Shia, Jinru, Millang, Brittanie, Ma, Jennifer, O’Reilly, Eileen M., Abou‐Alfa, Ghassan K.
izdano v Cancer Med (2020)

Noninvasive Detection of Polyclonal Acquired Resistance to FGFR Inhibition in Patients With Cholangiocarcinoma Harboring FGFR2 Alterations

od Varghese, Anna M., Patel, Juber, Janjigian, Yelena Y., Meng, Fanli, Selcuklu, S. Duygu, Iyer, Gopakumar, Houck-Loomis, Brian, Harding, James J., O’Reilly, Eileen M., Abou-Alfa, Ghassan K., Lowery, Maeve A., Berger, Michael F.
izdano v JCO Precis Oncol (2021)

A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies

od Harding, James J., Do, Richard K., Dika, Imane El, Hollywood, Ellen, Uhlitskykh, Khrystyna, Valentino, Emily, Wan, Peter, Hamilton, Casey, Feng, Xiaoxing, Johnston, Amanda, Bomalaski, John, Li, Chien-Feng, O’Reilly, Eileen M., Abou-Alfa, Ghassan K.
izdano v Cancer Chemother Pharmacol (2018)

PTEN Loss-of-Function Alterations Are Associated With Intrinsic Resistance to BRAF Inhibitors in Metastatic Melanoma

od Catalanotti, Federica, Cheng, Donavan T., Shoushtari, Alexander N., Johnson, Douglas B., Panageas, Katherine S., Momtaz, Parisa, Higham, Catherine, Won, Helen H., Harding, James J., Merghoub, Taha, Rosen, Neal, Sosman, Jeffrey A., Berger, Michael F., Chapman, Paul B., Solit, David B.
izdano v JCO Precis Oncol (2017)

A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases

od Harding, James J., Catalanotti, Federica, Munhoz, Rodrigo R., Cheng, Donavan T., Yaqubie, Amin, Kelly, Nicole, McDermott, Gregory C., Kersellius, Romona, Merghoub, Taha, Lacouture, Mario E., Carvajal, Richard D., Panageas, Katherine S., Berger, Michael F., Rosen, Neal, Solit, David B., Chapman, Paul B.
izdano v Oncologist (2015)

Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies

od Abdel-Wahab, Omar, Klimek, Virginia M., Gaskell, Alisa A., Viale, Agnes, Cheng, Donavan, Kim, Eunhee, Rampal, Raajit, Bluth, Mark, Harding, James J., Callahan, Margaret K., Merghoub, Taha, Berger, Michael F., Solit, David B., Rosen, Neal, Levine, Ross L., Chapman, Paul B.
izdano v Cancer Discov (2014)